Gonadotropin-releasing-hormone (GnRH) agonists are routinely used to manage recurrent nonmetastatic prostate cancer, but the therapy results in hypogonadism, which has adverse consequences including ...
Exploring the patient journey through breast cancer referral and treatment, and how nurses in primary care can support ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback